BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 36768623)

  • 1. Detection of Circulating Tumor Cell-Related Markers in Gynecologic Cancer Using Microfluidic Devices: A Pilot Study.
    Law KS; Huang CE; Chen SW
    Int J Mol Sci; 2023 Jan; 24(3):. PubMed ID: 36768623
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessment of a six gene panel for the molecular detection of circulating tumor cells in the blood of female cancer patients.
    Obermayr E; Sanchez-Cabo F; Tea MK; Singer CF; Krainer M; Fischer MB; Sehouli J; Reinthaller A; Horvat R; Heinze G; Tong D; Zeillinger R
    BMC Cancer; 2010 Dec; 10():666. PubMed ID: 21129172
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Detection of circulating tumour cells may add value in endometrial cancer management.
    Ni T; Sun X; Shan B; Wang J; Liu Y; Gu SL; Wang YD
    Eur J Obstet Gynecol Reprod Biol; 2016 Dec; 207():1-4. PubMed ID: 27756035
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Circulating Tumor Cell Detection by Liquid Biopsy during Early-Stage Endometrial Cancer Surgery: A Pilot Study.
    Francini S; Duraes M; Rathat G; Macioce V; Mollevi C; Pages L; Ferrer C; Cayrefourcq L; Alix-Panabières C
    Biomolecules; 2023 Feb; 13(3):. PubMed ID: 36979364
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New Labyrinth Microfluidic Device Detects Circulating Tumor Cells Expressing Cancer Stem Cell Marker and Circulating Tumor Microemboli in Hepatocellular Carcinoma.
    Wan S; Kim TH; Smith KJ; Delaney R; Park GS; Guo H; Lin E; Plegue T; Kuo N; Steffes J; Leu C; Simeone DM; Razimulava N; Parikh ND; Nagrath S; Welling TH
    Sci Rep; 2019 Dec; 9(1):18575. PubMed ID: 31819089
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Circulating tumor cells in breast cancer: detection systems, molecular characterization, and future challenges.
    Lianidou ES; Markou A
    Clin Chem; 2011 Sep; 57(9):1242-55. PubMed ID: 21784769
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Personalized Circulating Tumor DNA Biomarkers Dynamically Predict Treatment Response and Survival In Gynecologic Cancers.
    Pereira E; Camacho-Vanegas O; Anand S; Sebra R; Catalina Camacho S; Garnar-Wortzel L; Nair N; Moshier E; Wooten M; Uzilov A; Chen R; Prasad-Hayes M; Zakashansky K; Beddoe AM; Schadt E; Dottino P; Martignetti JA
    PLoS One; 2015; 10(12):e0145754. PubMed ID: 26717006
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of a novel circulating tumor DNA next-generating sequencing platform with circulating tumor cells (CTCs) and CTC clusters in metastatic breast cancer.
    Davis AA; Zhang Q; Gerratana L; Shah AN; Zhan Y; Qiang W; Finkelman BS; Flaum L; Behdad A; Gradishar WJ; Platanias LC; Cristofanilli M
    Breast Cancer Res; 2019 Dec; 21(1):137. PubMed ID: 31801599
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Disseminated tumor cells in bone marrow may affect prognosis of patients with gynecologic malignancies.
    Banys M; Solomayer EF; Becker S; Krawczyk N; Gardanis K; Staebler A; Neubauer H; Wallwiener D; Fehm T
    Int J Gynecol Cancer; 2009 Jul; 19(5):948-52. PubMed ID: 19574790
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Posttreatment surveillance and diagnosis of recurrence in women with gynecologic malignancies: Society of Gynecologic Oncologists recommendations.
    Salani R; Backes FJ; Fung MF; Holschneider CH; Parker LP; Bristow RE; Goff BA
    Am J Obstet Gynecol; 2011 Jun; 204(6):466-78. PubMed ID: 21752752
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Isolation of breast cancer and gastric cancer circulating tumor cells by use of an anti HER2-based microfluidic device.
    Galletti G; Sung MS; Vahdat LT; Shah MA; Santana SM; Altavilla G; Kirby BJ; Giannakakou P
    Lab Chip; 2014 Jan; 14(1):147-56. PubMed ID: 24202699
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predictive value of circulating tumor cells (CTCs) captured by microfluidic device in patients with epithelial ovarian cancer.
    Lee M; Kim EJ; Cho Y; Kim S; Chung HH; Park NH; Song YS
    Gynecol Oncol; 2017 May; 145(2):361-365. PubMed ID: 28274569
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Wedge-shaped microfluidic chip for circulating tumor cells isolation and its clinical significance in gastric cancer.
    Yang C; Zhang N; Wang S; Shi D; Zhang C; Liu K; Xiong B
    J Transl Med; 2018 May; 16(1):139. PubMed ID: 29792200
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Discovery of Novel Circulating Cancer-Related Cells in Circulation Poses New Challenges to Microfluidic Devices for Enrichment and Detection.
    Wu M; Huang Y; Zhou Y; Zhao H; Lan Y; Yu Z; Jia C; Cong H; Zhao J
    Small Methods; 2022 Jul; 6(7):e2200226. PubMed ID: 35595707
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genome‑wide copy number analysis of circulating tumor cells in breast cancer patients with liver metastasis.
    Zou L; Imani S; Maghsoudloo M; Shasaltaneh MD; Gao L; Zhou J; Wen Q; Liu S; Zhang L; Chen G
    Oncol Rep; 2020 Sep; 44(3):1075-1093. PubMed ID: 32705227
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detection of HER2-positive Circulating Tumor Cells Using the LiquidBiopsy System in Breast Cancer.
    Chen W; Zhang J; Huang L; Chen L; Zhou Y; Tang D; Xie Y; Wang H; Huang C
    Clin Breast Cancer; 2019 Feb; 19(1):e239-e246. PubMed ID: 30472074
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pattern of failure and value of follow-up procedures in endometrial and cervical cancer patients.
    Sartori E; Pasinetti B; Carrara L; Gambino A; Odicino F; Pecorelli S
    Gynecol Oncol; 2007 Oct; 107(1 Suppl 1):S241-7. PubMed ID: 17826824
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Recent advances in isolation and detection of circulating tumor cells with a microfluidic system].
    Cao R; Zhang M; Yu H; Qin J
    Se Pu; 2022 Mar; 40(3):213-223. PubMed ID: 35243831
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of CA27.29 and Circulating Tumor Cells Before and at Different Times After Adjuvant Chemotherapy in Patients with Early-stage Breast Cancer - The SUCCESS Trial.
    Hepp P; Andergassen U; Jäger B; Trapp E; Alunni-Fabbroni M; Friedl TW; Hecker N; Lorenz R; Fasching P; Schneeweiss A; Fehm T; Janni W; Rack B
    Anticancer Res; 2016 Sep; 36(9):4771-6. PubMed ID: 27630326
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence and prognostic value of disseminated tumor cells in primary endometrial, cervical and vulvar cancer patients.
    Walter CB; Taran FA; Wallwiener M; Rothmund R; Kraemer B; Krawczyk N; Blassl C; Melcher C; Wallwiener D; Fehm T; Hartkopf AD
    Future Oncol; 2014 Jan; 10(1):41-8. PubMed ID: 24328408
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.